The adoption of telemedicine and remote monitoring technologies in ophthalmology to accelerate the market growth, says Fact.MR in its new market rese ...

Repatha: the frontline of US price battles Amgen's Repatha became the first ... with rigid medical devices such as hearing aids, dental implants and prosthetic hands being manufactured.

Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...

Delray Beach, FL, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The global orthopedic implants market, valued at US$20.13 billion in 2023, is forecasted to grow at a robust CAGR of 4.8%, reaching US$20.94 ...

New Delhi, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The global dental implants and prosthetics contract manufacturing market was valued at US$ 1.55 billion in 2024 and is projected to reach US$ 3.23 ...

Amgen's Q4 earnings beat expectations, showcasing robust performance for the company's growth strategy. Click here to read ...

Amgen Inc. sees the potential for 2025 revenues to top Wall Street estimates thanks to growth in cholesterol and cancer drugs ...

Amgen reported strong fourth-quarter earnings, driven by strategic acquisitions and robust product sales growth.

After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...

Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug ...

Amgen’s mysterious obesity asset will remain a mystery for a bit longer—the FDA has put the candidate’s phase 1 trial ...

New Delhi, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The global dental implants and prosthetics contract manufacturing market was valued at US$ 1.55 billion in 2024 and is projected to reach US$ 3.23 billion ...